The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

The University of North Texas at Dallas' new STEM center will train local students for high-demand, high-wage jobs in the medical field. The development ...

Every biotech lab in the world leaks money in a silent way. Through lost time. Not broken equipment or failed experiments, but from something far less visible: information that exists somewhere in the ...

Complete national, international, and economic updates essential for UPSC preparation—covering governance, global affairs, ...

If you are a Class 12 science student, chances are you have come across this question more than once. Should you choose Pharmacy or Biotechnology? Both sound promising. Both fall under life sciences.

The CBSE Class 12 Sociology Deleted Syllabus 2025–26 has been introduced by the Central Board of Secondary Education to ensure a more balanced, student-friendly, and competency-based curriculum. As ...

CBSE Class 12 Accountancy Deleted Syllabus 2025–26 - The Central Board of Secondary Education (CBSE) has released the details regarding the CBSE Class 12 Accountancy Deleted Syllabus for the Academic ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

In preparation for the spring 2026 semester, all instructors who conduct a sponsored class project or capstone project in collaboration with an outside sponsor or provider of data (even if no funds ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

This American family takes on two major off-grid projects with only 12 hours to finish everything. The day turns into a race against time as weather, materials, and coordination all fight back. Their ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...